DSpace@İnönü

Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting

Basit öğe kaydını göster

dc.contributor.author Cicek, D
dc.contributor.author Pekdemir, H
dc.contributor.author Kalay, N
dc.contributor.author Binici, S
dc.contributor.author Altay, H
dc.contributor.author Muderrisoglu, H
dc.date.accessioned 2022-10-19T08:16:33Z
dc.date.available 2022-10-19T08:16:33Z
dc.date.issued 2010
dc.identifier.uri http://hdl.handle.net/11616/82082
dc.description.abstract Background: The efficacy of drug-eluting stents has been shown in randomized trials, but some controversy exists regarding which stent sirolimus-eluting or paclitaxel-eluting is more effective in unselected Turkish patients. Therefore, we investigated the clinical outcomes of patients who were treated with one type of these drug-eluting stents in the real world.
dc.description.abstract Methods: We created a registry and prospectively analyzed data on a consecutive series of all patients who presented to our institution with symptomatic coronary artery disease between February 2005 and March 2007 and who were treated with the sirolimus- or the paclitaxel-eluting stent. The follow-up period after stent implantation was approximately 24 months. The primary end point was a major cardiac event, and the secondary end point was stent thrombosis. Informed consent was obtained from all subjects, and the study protocol was approved by the local ethical committee.
dc.description.abstract Results: In total, 204 patients were treated with either the sirolimus-eluting stent (n = 103) or the paclitaxel-eluting stent (n = 101). The lesions in the 2 arms of the study were treated similarly by conventional technique. At 24-month follow-up, patients who received the paclitaxel-eluting stent showed significantly higher rates of non-Q-wave myocardial infarction (1.9% vs 5.9%; P: .002), target vessel revascularization (1.9% vs 4.9%; P: .002), coronary artery bypass graft surgery (1.9% vs 6.9%; P: .001), and late stent thrombosis (1.9% vs 3.9%, P: .002).
dc.description.abstract Conclusions: Patients who received the sirolimus- eluting stent showed better clinical outcomes compared with those who had the paclitaxel-eluting-stent.
dc.description.abstract C1 [Cicek, Davran] Baskent Univ, Sch Med, Dept Cardiol, Antalya, Turkey.
dc.description.abstract [Pekdemir, Hasan] Inonu Univ, Sch Med, Dept Cardiol, Malatya, Turkey.
dc.description.abstract [Kalay, Nihat] Erciyes Univ, Sch Med, Dept Cardiol, Kayseri, Turkey.
dc.description.abstract [Binici, Sueleyman; Altay, Hakan] Erciyes Univ, Sch Med, Dept Cardiol, Adana, Turkey.
dc.description.abstract [Muderrisoglu, Haldun] Baskent Univ, Sch Med, Dept Cardiol, TR-06490 Ankara, Turkey.
dc.source INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
dc.title Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting
dc.title Stents in an Unselected Population With Coronary Artery Disease:
dc.title 24-Month Outcomes of Patients in a Prospective Non-randomized Registry
dc.title in Southern Turkey


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster